NHS leaders pour scorn on star ratings
October 31, 2003New star ratings for all NHS trusts have been attacked by leaders in primary and secondary care, who say they …
PCTs to hold balance of power in community pharmacy
October 31, 2003Pharmacy leaders have welcomed plans to protect local pharmacies from greater competition, but say crucial detail must now be agreed …
Breakthrough in consultant contract talks
October 31, 2003Doctors' leaders have declared a breakthrough in the long-running and bitter dispute over the new consultants' contract.The halving of the …
PR heavyweights launch new agency
October 29, 2003Former managing directors of Shire Health London and Cohn & Wolfe Healthcare have joined forces to launch a new independent, …
New R&D chief as Merck files Erbitux
October 29, 2003German pharmaceutical Merck KgaA has appointed a new head of clinical research and development following a major R&D re-organisation. Dr …
Liver test takes shine off Exanta
October 29, 2003AstraZeneca has admitted that patients on its new anti-clotting drug Exanta will need liver tests, denting the drug's profile as …
US approval for breakthrough diabetes device
October 29, 2003The first integrated glucose meter and insulin pump has been approved by the FDA, bringing the goal of an 'artificial …
Pharmacy reform must look at ‘bigger picture’
October 29, 2003MPs have criticised a report recommending opening up community pharmacy to greater competition, saying its value had been misunderstood.David Hinchcliffe, …
Generic threat to Lilly’s biggest seller
October 29, 2003A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, …
AstraZeneca buoyed by Crestor clearance
October 29, 2003AstraZeneca's new statin drug has received unanimous approval by a key FDA panel, and now looks set to be launched …
CROs continue to extend global reach
October 29, 2003Contract research organisations from Europe and the US are continuing to expand their operations in order to meet the pharmaceutical …
Call for free price-setting across Europe
October 29, 2003Pharmaceutical companies should be allowed to set their own prices in all European Union countries in order to bring a …
GSK and Novartis settle over Augmentin
October 29, 2003GlaxoSmithKline has reached an agreement with Novartis in its court action over stolen trade secrets for its antibiotic Augmentin.Novartis will …
OGS withdraws CAT offer recommendation
October 29, 2003Oxford GlycoSciences has withdrawn its support of Cambridge Antibody Technology's £110 million all-share bid for the company, despite believing a …
Foundation hospitals survive Labour revolt
October 29, 2003Plans for foundation hospitals have been narrowly passed by the House of Commons despite a revolt by Labour MPs that …
Schering’s Angeliq approved in Europe
October 29, 2003Schering's new low dose HRT product Angeliq has gained mutual recognition in the European Union, with launches expected across the …
Pharma urged to reduce animal testing
October 29, 2003The pharmaceutical industry should test more drugs in humans at a pre-clinical stage to reduce numbers of primates used, a …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
